Company
Arena Pharmaceuticals
- Business model
- B2B
Record updated 28 September 2026
About
Arena made its debut as a public company in 2000, with a focus (then and now) on discovering, developing and commercializing novel drugs that target G protein-coupled receptors (GPCRs).